Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor

NCT03279601 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: Capecitabine, Dacarbazine
DRUG: Capecitabine, Temozolomide

Sponsor

Peking University